Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
21SEP

Claret closes €575m debt fund

1 min read
16:52UTC

Claret Capital Partners closed a €575 million growth debt fund on 7 September, a 94% step-up on the €297 million it raised for the predecessor fund in 2022.

TechnologyDeveloping
Key takeaway

European growth debt capacity has nearly doubled since 2022 at this one lender.

Claret Capital Partners closed a €575 million growth debt fund on 7 September, a 94% step-up on the €297 million it raised for the predecessor fund in 2022⁠1. Growth debt lends against future revenue rather than against assets, so a company borrows without issuing shares and without a valuation event. Claret joined the Open Cosmos syndicate announced a week later, which is the pattern the instrument suits: a company with revenue history that wants capital without dilution. The British Business Bank reached the same instrument from the other end in July, proposing a debt fund for aerospace suppliers rather than an equity one. Doubling a fund of this kind in four years says the European lenders now believe there are enough such companies to lend to, which is a quieter claim about the market than any equity round makes, and a more testable one.

Deep Analysis

In plain English

Claret Capital Partners, the same firm that took part in Open Cosmos's funding round, has finished raising a €575m fund. Unlike a normal investment fund that buys shares in companies, this one lends money to growing companies, a type of financing called venture debt. The new fund is almost double the size of The Firm's previous one, which closed at €297m in 2022, suggesting lenders see more demand for this kind of loan from growth-stage European companies than they did four years ago.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Claret Capital Partners· 21 Sept 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.